Beginning Cash (Annual)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Sanara MedTech Inc. (SMTI) had Beginning Cash of $15.88M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$103.12M
Net Income	$-37.56M
Cost of Goods Sold	$7.52M
Gross Profit	$95.60M
Operating Expenses	$95.81M
Operating Income	$7.30M
Non-Operating Income/Expense	$-7.70M
Pre-Tax Income	$-0.39M
Normalized Pre-Tax Income	$-0.40M
Income after Taxes	$-0.39M
Income from Continuous Operations	$-0.39M
Consolidated Net Income/Loss	$-37.57M
Normalized Income after Taxes	$-0.40M
EBIT	$7.30M
EBITDA	$11.53M
Weighted-Average Shares Outstanding (Basic)	8.62M
Weighted-Average Shares Outstanding (Diluted)	8.62M
Earnings per Share (EPS) (Basic)	$-4.36
Earnings per Share (EPS) (Diluted)	$-4.36
Balance Sheet Financials
Current Assets	$33.54M
Property, Plant, and Equipment	$0.46M
Long-Term Assets	$39.40M
Total Assets	$72.94M
Current Liabilities	$18.63M
Long-Term Debt	$45.97M
Long-Term Liabilities	$48.39M
Total Liabilities	$67.01M
Common Equity	$5.93M
Tangible Shareholders Equity	$-16.31M
Shareholders Equity	$5.93M
Common Shares Outstanding	8.95M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.79M
Cash Flow from Investing Activities	$-14.97M
Cash Flow from Financial Activities	$8.89M
Beginning Cash	$15.88M
End Cash	$16.58M
Increase/Decrease in Cash	$0.70M
Stock-Based Compensation	$5.15M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.80
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.89
Debt to Equity Ratio	7.75
Gross Margin	92.71%
Operating Margin	7.08%
EBIT Margin	7.08%
EBITDA Margin	11.18%
Pre-Tax Profit Margin	-0.38%
Profit Margin	-36.43%
Free Cash Flow	$2.22M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.41
Inventory Turnover	1.90
Receiveable Turnover	8.59
Days Sales in Receivables	42.47
Return on Equity	-6.63%
Return on Tangible Equity	2.41%
Return on Assets	-0.54%
Return on Investments	-0.76%
Book Value Per Share	$0.66
Free Cash Flow per Share	$0.26
Operating Cash Flow per Share	$0.79

Data from Zacks Investment Research, Inc.